These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1472461)

  • 1. Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala and their interactions with aromatase inhibitors.
    Kadohama N; Yarborough C; Zhou D; Chen S; Osawa Y
    J Steroid Biochem Mol Biol; 1992 Dec; 43(7):693-701. PubMed ID: 1472461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic efficiency of expressed aromatase following site-directed mutagenesis.
    Kadohama N; Zhou D; Chen S; Osawa Y
    Biochim Biophys Acta; 1993 May; 1163(2):195-200. PubMed ID: 8490051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.
    Purba HS; King EJ; Richert P; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):215-9. PubMed ID: 8142297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study.
    Kao YC; Korzekwa KR; Laughton CA; Chen S
    Eur J Biochem; 2001 Jan; 268(2):243-51. PubMed ID: 11168357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible inhibition of human placental microsomal aromatase by CGS 18320B and other non-steroidal compounds.
    Bullion KA; Osawa Y; Braun DG
    Endocr Res; 1990; 16(2):255-67. PubMed ID: 2140551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different catalytic properties and inhibitor responses of the goldfish brain and ovary aromatase isozymes.
    Zhao J; Mak P; Tchoudakova A; Callard G; Chen S
    Gen Comp Endocrinol; 2001 Aug; 123(2):180-91. PubMed ID: 11482939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors.
    Häusler A; Schenkel L; Krähenbühl C; Monnet G; Bhatnagar AS
    J Steroid Biochem; 1989 Jul; 33(1):125-31. PubMed ID: 2527324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.
    Steele RE; Mellor LB; Sawyer WK; Wasvary JM; Browne LJ
    Steroids; 1987; 50(1-3):147-61. PubMed ID: 2973160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.
    Payne EJ; Ingley E; Dick IM; Wilson SG; Bond CS; Prince RL
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2998-3002. PubMed ID: 19470632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel aromatase inhibitors.
    Bhatnagar AS; Häusler A; Schieweck K; Browne LJ; Bowman R; Steele RE
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):363-7. PubMed ID: 2147860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A site-directed mutagenesis study of human placental aromatase.
    Zhou DJ; Korzekwa KR; Poulos T; Chen SA
    J Biol Chem; 1992 Jan; 267(2):762-8. PubMed ID: 1730667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg.
    Zhou DJ; Pompon D; Chen SA
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):410-4. PubMed ID: 1988941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
    Santen RJ; Demers LM; Lynch J; Harvey H; Lipton A; Mulagha M; Hanagan J; Garber JE; Henderson IC; Navari RM
    J Clin Endocrinol Metab; 1991 Jul; 73(1):99-106. PubMed ID: 1646219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain.
    Wozniak A; Holman SD; Hutchison JB
    J Steroid Biochem Mol Biol; 1992 Oct; 43(4):281-7. PubMed ID: 1390279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro.
    Lamberts SW; Bruining HA; Marzouk H; Zuiderwijk J; Uitterlinden P; Blijd JJ; Hackeng WH; De Jong FH
    J Clin Endocrinol Metab; 1989 Oct; 69(4):896-901. PubMed ID: 2550511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
    Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR 20492 and MR 20494: two indolizinone derivatives that strongly inhibit human aromatase.
    Auvray P; Sourdaine P; Moslemi S; Séralini GE; Sonnet P; Enguehard C; Guillon J; Dallemagne P; Bureau R; Rault S
    J Steroid Biochem Mol Biol; 1999; 70(1-3):59-71. PubMed ID: 10529003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450.
    Zhou D; Cam LL; Laughton CA; Korzekwa KR; Chen S
    J Biol Chem; 1994 Jul; 269(30):19501-8. PubMed ID: 8034720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening.
    Zhou DJ; Pompon D; Chen SA
    Cancer Res; 1990 Nov; 50(21):6949-54. PubMed ID: 2208160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.